Kalaris Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KLRS)

Historical Holders for Q1 2025

Symbol
KLRS on Nasdaq
CUSIP
482929106
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
18.7M
All holders as of March 31, 2025
Q1 2025
Shares, excl. options
82
Holdings value
$657
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
2
Number of buys
2
Average Value change %
0%
Average buys %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Kalaris Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KLRS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Samsara BioCapital, L.P. 61.2% $91.7M 11.4M Samsara BioCapital, L.P. Mar 18, 2025
GILEAD SCIENCES, INC. 3.9% $5.79M 723K GILEAD SCIENCES, INC. Mar 18, 2025

Institutional Holders of Kalaris Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KLRS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 82 $657 +$657 $8.01 2